![Mark Wisniewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Wisniewski
Direttore/Membro del Consiglio presso Field Medical, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Steven Mickelsen | M | - |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | 2 anni |
Louise Janssen-Counotte | F | 59 |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | 1 anni |
Bart Schade | M | - |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 3 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Mark Wisniewski
- Contatti personali